ABSTRACT - 594414 The disclosure relates to the use of compounds with fused amino pyridine core represented by the structural formulae shown herein for the treatment of malignancies associated with brain and lung. The oral administration of compounds of the instant application results in effective brain penetration and provides for non-intrusive treatment of brain and lung tumors.
